RxDoctor Payments Data

Patricia Keegan, NP

Adult Health · Atlanta, GANPI 1023308301

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $156,956 of the $223,786 with a category attached, or 70.1%. Edwards Lifesciences accounts for 82.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $66,885 and has fallen 100.0% since, to $15 in 2025. Among adult health clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$223,786in general payments, 2019–2025

Across 470 payments — averaging $476.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$184K
  • Abbott$37K
  • Medtronic$2K
  • Boston Scientific$455
  • AstraZeneca$140
  • Shockwave Medical, Inc$100
  • plus $53 from 3 others

What the payments were for

  • Consulting fees$156,95670%
  • Speaking & faculty fees$15,0507%
  • Travel & lodging$35,33116%
  • Food & beverage$16,3117%
  • Education$1370%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$223,786 in reported general payments places this provider in the 95th percentile of 577 adult health providers in Georgia.

See all adult health providers in Georgia

Medicare billing

Part B allowed, 2024
$4,482
Medicare patients
39
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$9,389

Paid to pharmacies, not to this prescriber.

Other adult health in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →